Helmholtz Gemeinschaft


Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells

Item Type:Article
Title:Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells
Creators Name:Chirasani, S.R. and Markovic, D.S. and Synowitz, M. and Eichler, S.A. and Wisniewski, P. and Kaminska, B. and Otto, A. and Wanker, E. and Schaefer, M. and Chiarugi, P. and Meier, J.C. and Kettenmann, H. and Glass, R.
Abstract:Transferrin receptors (TfR) are overexpressed in brain tumors, but the pathological relevance has not been fully explored. Here, we show that TfR is an important downstream effector of ets transcription factors that promotes glioma proliferation and increases glioma-evoked neuronal death. TfR mediates iron accumulation and reactive oxygen formation and thereby enhanced proliferation in clonal human glioma lines, as shown by the following experiments: (1) downregulating TfR expression reduced proliferation in vitro and in vivo; (2) forced TfR expression in low-grade glioma accelerated proliferation to the level of high-grade glioma; (3) iron and oxidant chelators attenuated tumor proliferation in vitro and tumor size in vivo. TfR-induced oxidant accumulation modified cellular signaling by inactivating a protein tyrosine phosphatase (low-molecular-weight protein tyrosine phosphatase), activating mitogen-activated protein kinase and Akt and by inactivating p21/cdkn1a and pRB. Inactivation of these cell cycle regulators facilitated S-phase entry. Besides its effect on proliferation, TfR also boosted glutamate release, which caused N-methyl-D: -aspartate-receptor-mediated reduction of neuron cell mass. Our results indicate that TfR promotes glioma progression by two mechanisms, an increase in proliferation rate and glutamate production, the latter mechanism providing space for the progressing tumor mass.
Keywords:Neuroscience, Neuro-Oncology, Glioma, ETS, Free Radicals, Oxidative Stress, Animals, Mice, Rats
Source:Journal of Molecular Medicine
Page Range:153-167
Date:February 2009
Official Publication:https://doi.org/10.1007/s00109-008-0414-3
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library